Financing, Equity Capital Markets

Cara Therapeutics Inc.

07/19
|
$126.5 Million
Piper Sandler served as bookrunner for Cara Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$150.0 Million
e
Personalis, Inc.
ATM Program Common Stock
Joint Placement Agent
s
Avalo Therapeutics
Confidentially Marketed Follow-On
Active Bookrunner
e
Nektar Therapeutics
Follow-On Offering
Active Bookrunner
d
Allogene Therapeutics, Inc.
Follow-On Offering
Passive Bookrunner
w
Inovio Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Financial Advisor
$150.0 Million
e
Aardvark Therapeutics
ATM Program Common Stock
Sole Placement Agent
e
CytomX Therapeutics Inc.
Follow-On Offering
Active Bookrunner
$538.0 Million
s
MiniMed Inc.
Initial Public Offering
Passive Bookrunner
$413.7 Million
d
Nurix
ATM Program Common Stock
Sole Placement Agent
$240.0 Million
d
d
Moxe Health Corporation
Moxe Health Corporation has received a majority investment from BV Investment Partners
Financial Advisor
3
Medline Industries
Follow-On
Passive Bookrunner
$400.0 Million
s
Generate Biomedicines, Inc.
Initial Public Offering
Passive Bookrunner
s
Zura Bio
Confidentially Marketed Follow-On Offering
Active Bookrunner
f
OKYO Pharma
Confidentially Marketed Follow-On Offering
Financial Advisor
s
Nektar Therapeutics
Follow-On Offering
Active Bookrunner
$94.5 Million
t
Lexicon Pharmaceuticals, Inc.
CMFO and PIPE
Active Bookrunner

© 2026 Piper Sandler Companies. Since 1895. All rights reserved.